A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...

VALENCIA, Calif., April 15, 2025 /PRNewswire/ -- Cunard's iconic Event Voyages are curated in partnership with the biggest names in entertainment, and now the luxury cruise line has unveiled part ...

TAIPEI (Reuters) - Taiwan's first phase of tariff talks with the United States went "smoothly" and the government hopes to take this challenge as an opportunity to promote a new Taiwan-plus-the ...

It is for this reason that should the Champions League winners have also qualified for the league phase via their domestic league position, the club with the best individual coefficient of all the ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, April 17, 2025, the moon is 19 days old and is in the Waning Gibbous phase of its lunar ...

What happens if the UEFA Europa League winners have already qualified for the 2025/26 UEFA Champions League via their domestic league position? Twenty-five teams will qualify automatically by ...

Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug.

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

This all changed on the TV side from Phase 4 onwards as any show after WandaVision was very much part of the MCU, sometimes critical even to understanding what happened in the movies they were ...

BMS was hoping to gain a label expansion for Camzyos based on the Phase III trial. Image credit: Shutterstock /Tada Images. Bristol Myers Squibb’s (BMS) Phase III trial investigating Camzyos ...

Credit: Komsan Loonprom/Shutterstock. Australia-based Neuren Pharmaceuticals has confirmed the primary goals for its double-blind, single Phase III pivotal trial of its drug NNZ-2591 in treating ...